Clinical Trial

An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease

Name: An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease — clinical trial record (NCT07764146)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

VY1706 first in human study in early Alzheimer's Disease is a multicenter dose escalation study

Trial Details

NCT Number	NCT07764146
Lead Sponsor	Voyager Therapeutics
Conditions	Alzheimer s Disease
Enrollment	18 participants
Start Date	2026-08-24
Primary Completion	2029-04-28 (estimated)
Study Completion	2029-04-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-13